scieee Science in your language
[en] (orig)

Anti-inflammatory and gut microbiota modulation potentials of flavonoids extracted from Passiflora foetida fruits

Abstract

This article belongs to the Section Nutraceuticals, Functional Foods, and Novel Foods.

Read accessible full text

Anti-inflammatory and gut microbiota modulation potentials of flavonoids extracted from Passiflora foetida fruits

Author: Han, Xiangpeng,Song, Ya,Huang, Riming,Zhu, Minqian,Li, Meiying,Requena, Teresa,Wang, Hong
Publisher: Multidisciplinary Digital Publishing Institute
Year: 2023
DOI: http://dx.doi.org/10.13039/501100011033
Source: https://digital.csic.es/bitstream/10261/332585/1/Anti-Inflammatory_and_Gut_Microbiota_Han.pdf
Ci a ion: Han, X.; Song, Y.; Huang,
R.; Zhu, M.; Li, M.; Requena, T.;
Wang, H. An i-In lamma o y and Gu
Mic obio a Modula ion Po en ials o
Fla onoids Ex ac ed om Passi lo a
oe ida F ui s. Foods 2023,12, 2889.
h ps://doi.o g/10.3390/
oods12152889
Academic Edi o : Vic o Rodo
Recei ed: 7 July 2023
Re ised: 25 July 2023
Accep ed: 25 July 2023
Published: 29 July 2023
Copy igh : © 2023 by he au ho s.
Licensee MDPI, Basel, Swi ze land.
This a icle is an open access a icle
dis ibu ed unde he e ms and
condi ions o he C ea i e Commons
A ibu ion (CC BY) license (h ps://
c ea i ecommons.o g/licenses/by/
4.0/).
oods
A icle
An i-In lamma o y and Gu Mic obio a Modula ion Po en ials
o Fla onoids Ex ac ed om Passi lo a oe ida F ui s
Xiangpeng Han 1,2,† , Ya Song 1,2,†, Riming Huang 1,2 , Minqian Zhu 1,2, Meiying Li 1,2, Te esa Requena 3,*
and Hong Wang 1,2,*
1Guangdong P o incial Key Labo a o y o Food Quali y and Sa e y, College o Food Science, Sou h China
Ag icul u al Uni e si y, Guangzhou 510642, China; [email p o ec ed] (X.H.); [email p o ec ed] (Y.S.);
[email p o ec ed] (R.H.); [email p o ec ed] (M.Z.); [email p o ec ed] (M.L.)
2Guangdong Labo a o y o Lingnan Mo de n Ag icul u e, Guangzhou 510642, China
3Ins i u o de In es igación en Ciencias de la Alimen ación CIAL (CSIC), Campus UAM Can oblanco,
28049 Mad id, Spain
*Co espondence: [email p o ec ed] (T.R.); [email p o ec ed] (H.W.)
†These au ho s con ibu ed equally o his wo k.
Abs ac :
This s udy aimed o explo e he an i-in lamma o y and gu mic obio a modula ion po en-
ials o la onoid- ich ac ion (PFF) ex ac ed om Passi lo a oe ida ui s. The esul s showed ha
PFF ma kedly educed he p oduc ion o ni ic oxide (NO), umo nec osis ac o
α
(TNF-
α
), and
in e leukin 6 (IL-6) in LPS-s imula ed RAW 264.7 cells. Meanwhile, PFF ea men also e ec i ely
dec eased he phospho yla ion le els o MAPK, PI3K/Ak , and NF-
κ
B signaling-pa hway- ela ed
p o eins (ERK, JNK, p38, Ak , and p65). Mo eo e , PFF had an impac on mic obial composi ion
and me aboli es in a ou -s age dynamic simula o o human gu mic obio a (BFBL gu model).
Speci ically, PFF exhibi ed he g ow h-p omo ing abili y o se e al bene icial bac e ia, including
Bi idobac e ium,En e ococcus,Lac obacillus, and Rosebu ia, and sho -chain a y acid (SCFA) gene a ion
abili y in gu mic obio a. In addi ion, spec oscopic da a e ealed ha PFF mainly con ained i e
la onoid compounds, which may be bioac i e compounds wi h an i-in lamma o y and gu mic o-
bio a modula ion po en ials. The e o e, PFF could be u ilized as a na u al an i-in lamma o y agen o
supplemen o heal h p oduc s.
Keywo ds:
Passi lo a oe ida ui s; la onoid- ich ac ion; an i-in lamma o y ac i i y; gu mic obio a;
sho -chain a y acids
1. In oduc ion
In lamma ion is a pi o al de ensi e esponse o he hos immune sys em agains
inju ious s imuli, such as oxic compounds, inju ed cells, pa hogenic o ganisms, and i -
adia ion [
1
,
2
]. I can p e en in ec ion caused by ea ly cell damage, elimina e damaged
cells o issue, and p omo e issue healing in he human body [
2
]. Howe e , excessi e o
uncon olled in lamma ion may esul in mul iple heal h diseases, including in lamma-
o y bowel disease (IBD), alle gies, me abolic synd ome, diabe es, au oimmune diseases,
ca dio ascula diseases, and cance [
3
]. Cu en ly, mos epidemiological s udies ha e
demons a ed ha in lamma ion- ela ed diseases a e closely in e ela ed wi h changes
in gu mic obio a [
4
–
6
]. Fo ins ance, he gu mic obio a composi ion o IBD pa ien s
exhibi s speci ic cha ac e is ics in compa ison wi h ha o non-IBD pa ien s [
7
]. O no e,
ce ain mic oo ganisms play i al oles in hos homeos asis, such as de ending agains i al
and pa hogenic in asion, abso bing nu ien s and ene gy, boos ing he immune sys em,
and imp o ing me abolism [
8
,
9
]. To da e, a ious pu i ied o syn he ic d ugs ha e been
explo ed o egula e and alle ia e in lamma ion- ela ed diseases, including immunomod-
ula o s, s e oids, and non-s e oidal an i-in lamma o y d ugs [
2
,
10
], whe eas he abo e
in e en ion d ugs gene ally p o ide limi ed clinical e ec i eness and ha e a se ies o
Foods 2023,12, 2889. h ps://doi.o g/10.3390/ oods12152889 h ps://www.mdpi.com/jou nal/ oods
Foods 2023,12, 2889 2 o 11
ad e se e ec s [
5
]. The e o e, he cu en esea ch ocuses on explo ing and de eloping
na u al an i-in lamma o y agen s de i ed om medicine ood homology plan s o he bal
medicines o enhance hei e icacy and sa e y.
In ecen yea s, e idence has been moun ing ha na u al la onoid-en iched oods,
such as esh ui s, ege ables, and ea, a e help ul in dec easing he isk o in lamma ion-
ela ed diseases [
11
]. Gene ally, la onoids possess excellen an i-in lamma o y p ope ies
o e ec i ely inhibi he in lamma o y p ocesses by dis up ing in lamma o y cy okine
elease and egula ing in lamma ion-associa ed signaling pa hways wi hou ha m ul side
e ec s [
5
]. Mo eo e , many s udies ha e e ealed ha die a y in ake o la onoids is
in ima ely ele an o he a ie y and composi ion o gu mic obio a [
12
]. Signi ican ly,
imp o ing he dys egula ed gu mic obio a is a momen ous a ge o new he apies o
in es inal in lamma ions [
13
]. Fo ins ance, la onoids can a enua e he hos in lamma-
o y esponse and educe he incidence o se e i y o IBD h ough in e ac ion wi h he
speci ic mic obio a and hei me aboli es [
14
]. Mo eo e , la onoids can also modula e
gu mic obio a by educing pa hogens (such as S aphylococcus,Pseudomonas,P o eus, e c.)
and inc easing p obio ics (such as Lac obacillus and Bi idobac e ia, e c.) [
15
], which can alle-
ia e he in lamma o y esponses by educing endo oxin p oduc ion, he eby p omo ing
gu heal h [
16
]. Hence, g owing a en ion o die a y nu i ion and illness p e en ion has
inc eased he daily demands o la onoid-en iched oods.
Passi lo a oe ida ui (Passi lo aceae) is an edible be y commonly consumed in opical
a eas, such as B azil and Sou h China, o ea ing acu e edema, auma ic co nea, conjunc-
i i is, and elie ing as hma [
17
]. To da e, he biological unc ions o P. oe ida ui s, includ-
ing an ibac e ial, an i-os eopo o ic, an i-in lamma o y, and an ioxidan ac i i ies, ha e been
epo ed [
11
]. Ou p e ious s udies showed ha P. oe ida ui s a e mainly ich in amino
acids (1097 mg/100 g), mine als (595.75 mg/100 g), suga s (3.34 g/100 g), o ganic acids
(0.24 mg/100 g), and polyphenols (284.4 mg/100 g), especially la onoids (239 mg/100 g),
which a e he majo componen o polyphenols [
18
]. Mo eo e , he la onoids we e ano he
main componen besides he polysaccha ides in he aqueous ex ac o P. oe ida ui s,
and he polysaccha ides ha e been cha ac e ized and demons a ed o possess excellen
immune-enhancing ac i i y [
18
–
20
]. Howe e , he composi ions and bioac i e bene i s o
la onoids om P. oe ida ui s s ill need o be disco e ed. The e o e, his p oposed s udy
aims o explo e he
in i o
an i-in lamma o y ac i i y and gu mic obio a modula ion
po en ial o PFF isola ed om P. oe ida ui s. This wo k will p o ide scien i ic e idence o
new uses o P. oe ida ui s and p omo e i s de elopmen and applica ion as a unc ional
ood o human heal h.
2. Ma e ials and Me hods
2.1. Ma e ials and Reagen s
The ma u e ui s o P. oe ida we e ha es ed om Dong ang ci y, Hainan p o ince,
China, in May 2021. RAW264.7 cells we e pu chased om Ame ican Type Cul u e Col-
lec ion (ATCC, Manassas, VA, USA). Dulbecco’s Modi ied Eagle’s medium (DMEM) was
ob ained om Gibco BRL (Gai he sbu g, MD, USA). Penicillin, s ep omycin, and e al
bo ine se um (FBS) we e p oduc s o HyClone (Logan, UT, USA). Lipopolysaccha ide
(LPS), 3-(4,5-dime hyl hiazol-2-yl)-2,5-diphenyl e azolium b omide (MTT), sul u ic acid,
i luo oace ic acid (TFA), enhanced chemiluminescence (ECL) ki , AB-8 mac opo ous esin,
and polyamide ille we e p oduced by Yuanye Bio echnology Co., L d. (Shanghai, China).
Bicinchoninic acid (BCA) ki , ni ic oxide (NO) de ec ion ki , ELISA ki s (TNF-
α
and IL-6),
and 4
0
,6-diamidino-2-phenylindole (DAPI) we e pu chased om Beyo ime Bio echnology
Co., L d. (Shanghai, China). Sephadex LH-20 dex an gel was pu chased om Gene al
Elec ic Co. (GE, Fai ield, CT, USA). The me hanol and ace oni ile we e p oduced by
Sigma Chemical Co. (S . Louis, MO, USA).
Foods 2023,12, 2889 3 o 11
2.2. P epa a ion o PFF
P. oe ida ui s we e sepa a ed and washed manually wi h dis illed wa e , hen d ied
in an o en. The d ied samples we e g ound and il a ed o p epa e P. oe ida powde , which
was p ese ed in an oxygen ba ie bag a
−
20
◦
C un il u he use. PFF ex ac ion and
isola ion we e pe o med acco ding o a p e ious s udy [
21
]. B ie ly, he c ude aqueous
ex ac o P. oe ida (AEP) was ob ained ia in usion wi h wa e (65
◦
C, powde : sol en , 1:10,
w/ ) o 2 h. The concen a ed AEP was p ecipi a ed by adding e hanol (96%) o e nigh a
4
◦
C, hen loaded on AB-8 mac opo ous esin column, elu ed sequen ially h ough dis illed
wa e and ex ac ed wi h e hanol (80%). Subsequen ly, he ex ac was u he pu i ied by a
polyamide column o ob ain PFF.
2.3. Cell Cul u e and Viabili y Assay
Cell iabili y was de e mined using he MTT me hod [
2
]. RAW264.7 cells (200
µ
L)
we e inocula ed in o a 96-well mic opla e (1
×
10
5
cells/mL) and cul u ed in DMEM
(con aining 10% FBS and 1% penicillin-s ep omycin) a 37
◦
C o 24 h. The medium was
eplaced wi h esh DMEM con aining a ious concen a ions o PFF (0, 6.25, 12.5, 25, 50,
100, 200, 400, and 600
µ
g/mL). A e incuba ion, he medium was emo ed, and 200
µ
L
o MTT solu ion (0.5 mg/mL) was added o a 96-well pla e, which was cul u ed o 4 h
a 37
◦
C. Subsequen ly, he pla e was washed wi h s e ile PBS, and 150
µ
L o DMSO was
added o each well. A e shaking in he da k o 15 min, he abso bance was eco ded a
570 nm by a mic opla e analyze (Molecula De ice, San Jose, CA, USA).
2.4. De e mina ion o NO and Cy okines
The p oduc ion o NO, TNF-
α
, and IL-6 was de e mined based on p e iously epo ed
me hods [
9
]. In b ie , RAW264.7 cells we e inocula ed in o a 48-well pla e (1
×
10
5
cells/mL)
con aining LPS (1
µ
g/mL) and PFF (0, 50, 100, and 200
µ
g/mL). A e 24 h o incuba ion,
he supe na an was ha es ed o quan i y NO, TNF-
α
, and IL-6 le els. NO p oduc ion was
de e mined using G iess eagen , and equal olumes o cul u e supe na an s and G iess
eagen we e mixed and eac ed o 15 min. Then, OD
540
was de e mined by a mic opla e
analyze . Meanwhile, he p oduc ion o IL-6 and TNF-
α
was de e mined using ELISA ki s.
2.5. Wes e n Blo Analysis
Wes e n blo was pe o med based on a p e iously desc ibed me hod [
22
]. In sho ,
RAW 264.7 cells we e inocula ed in o a 6-well pla e (1
×
10
5
cells/mL) and ea ed wi h LPS
(1
µ
g/mL) and PFF (0, 50, 100, and 200
µ
g/mL) o 24 h. A e incuba ion, he cells we e
ha es ed and lysed in adioimmunop ecipi a ion assay (RIPA) bu e . A e cen i uga ion
(12,000
×
g, 4
◦
C, 20 min), he p o ein concen a ion o he supe na an was quan i ied by
BCA Ki . Meanwhile, he samples and
×
5 loading bu e we e mixed and hea ed (100
◦
C,
10 min) o dena u e he p o ein comple ely. Then, 50
µ
g o o al p o ein was sepa a ed
by SDS-PAGE gel and ans e ed o a poly inylidene di luo ide memb ane, which was
blocked by 5% BSA and incuba ed wi h he p ima y an ibodies. A e ha , memb anes
we e u he incuba ed wi h he seconda y an ibody. Finally, p o ein bands we e eac ed
wi h ECL solu ions and isualized using an imaging sys em (GE, Chicago, IL, USA).
2.6. Immuno luo escence Analysis
Con ocal mic oscopy was pe o med as desc ibed by Duan e al. [
23
]. RAW264.7 cells
(1
×
10
5
cells/mL) we e p e ea ed in a 6-well pla e wi h LPS (1
µ
g/mL) and PFF (0, 100,
and 200
µ
g/mL). A e ha , cells we e collec ed and washed gen ly using s e ile PBS,
sequen ially ixed wi h 4% o maldehyde o 30 min, and pe meabilized wi h 1% T i on
X-100 o 30 min. A e wa d, ixed cells we e blocked by 5% BSA, washed and incuba ed
wi h p65 an ibody o e nigh . Subsequen ly, he cells we e incuba ed wi h FITC-labeled
second an ibody in da kness o 2 h, hen s ained wi h DAPI in da kness o 30 min. Images
we e obse ed using con ocal lase scanning mic oscopy (Leica, We zla , Ge many).
Foods 2023,12, 2889 4 o 11
2.7. Dynamic Simula o o he Gu Mic obiome
The p epa a ion o ecal samples was ca ied ou acco ding o a me hod epo ed by
Tang e al. [
24
]. Speci ically, esh ecal samples we e collec ed om i e heal hy human
olun ee s (BMI be ween 18.5 and 24.9 kg/m
2
) who did no ha e in es inal diseases o
had no aken an ibio ics o he p e ious h ee mon hs and ollowed a la onoid- ee die
o h ee days be o e ecal collec ion. The ecal samples we e immedia ely s o ed in an
anae obic ank and hen dilu ed in sodium phospha e bu e (0.1 M, pH 7.0) wi h sodium
hioglycola e and homogenized o ob ain a 20% (w/ ) eces slu y.
The BFBL gu model (Figu e S1) is a ou -s age eac o sys em ha simula es he small
in es ine (SI), ascending colon (R
1
), ans e se colon (R
2
), and descending colon (R
3
) o
humans
in i o
[
25
]. B ie ly, h ee colon eac o s (R
1
, R
2
, and R
3
) we e i s illed wi h
nu i i e medium (pH 2.0) in a olume o 250, 400, and 300 mL, espec i ely. Subsequen ly,
each colon eac o was inocula ed wi h 20 mL o eces slu y, hen con inuously s i ed
(150 pm) wi h an Agima ic N magne ic s i e wi h hea ing (Selec a, Spain), and he
empe a u e was main ained a 37
◦
C. Meanwhile, he sys em was main ained as anae obic
by con inuously lushing N
2
, and pH alues o he colonic eac o s we e au oma ically
adjus ed o main ain 5.7 ±0.2 in he R1, 6.3 ±0.2 in he R2, and 6.8 ±0.2 in he R3.
To main ain gu homeos asis, he small in es ine (SI) was ed 75 mL o nu ien medium
(pH 2.0) and 40 mL o a i icial panc ea ic juice mix u e (6 g/L cholangium, 1.9 g/L
po cine panc ea ic ypsin, and 12.5 g/L NaHCO
3
) h ee imes pe day o wo weeks.
Small in es ine diges ion was conduc ed a 37
◦
C, and essel con en s we e au oma ically
ans e ed o he ollowing colonic compa men , which ac i a ed he anspo o colonic
con en be ween R
1
, R
2
, and R
3
eac o s egula ed by le el senso s o main ain a cons an
eac o olume. Du ing he eeding p ocess, all compa men s we e lushed wi h ni ogen
gas o main ain an anae obic s a e. A e a wo-week s abiliza ion pe iod (CK), he BFBL
gu model was subjec ed o a one-week in ake pe iod by adding PFF (4 g/L) o he nu i i e
medium, ollowed by a one-week washou pe iod (WO) wi h he addi ion o nu ien
medium. Finally, samples we e collec ed om h ee colon eac o s daily h oughou he
s udy pe iod and p ese ed a −20 ◦C un il use.
2.8. Mic obio a Composi ion Analysis
Genomic DNA o mic obial samples om R
1
, R
2
, and R
3
eac o s was ex ac ed as
p e iously epo ed by Requena e al. [
25
]. The gene-speci ic p ime s, s anda ds, amplicon
size, and ampli ica ion condi ions o he quan i ica ion o a ge ed mic obial g oups a e
lis ed in Table S1. The SYBR G een-based RT-qPCR assay was conduc ed o quan i y DNA
samples and s anda ds using a ViiA7 Real-Time PCR Sys em (The mo Fishe Scien i ic,
Wal ham, MA, USA).
2.9. SCFAs Analysis
The BFBL gu model samples (1 mL) we e collec ed daily om each eac o (R
1
, R
2
,
and R
3
) o SCFAs analysis du ing each pe iod. SCFAs we e quan i ied by a me hod
epo ed by Ba oso e al. [
26
]. In sho , he il e ed (0.22
µ
m) samples we e analyzed by
an HPLC sys em equipped wi h Rezex ROA-O ganic Acids column (300 mm
×
7.8 mm,
Phenomenex, Maccles ield, UK) and UV-975 de ec o (Jasco, Tokyo, Japan). The mobile
phase was 0.005 M sul u ic acid solu ion wi h a linea g adien o 0.6 mL/min, and elu ion
cu es we e moni o ed a 210 nm. Calib a ion cu es we e es ablished o SCFAs wi h
concen a ions anging om 1 o 100 mM.
2.10. Isola ion o he Main Fla onoids in PFF
The ex ac ion and sepa a ion o he main la onoids in PFF we e conduc ed based on
p e ious s udies [
27
,
28
], wi h sligh modi ica ions. Fi s ly, PFF was pu i ied by pe mea ion
on he Sephadex LH-20 column using me hanol as he mobile phase (0.5 mL/min). Subse-
quen ly, he collec ed ac ion was subjec ed o g adien p epa a i e liquid ch oma og aphy,
conduc ed using he P ep 150 LC se wi h a 2988 pho odiode a ay de ec o , and connec ed
Foods 2023,12, 2889 5 o 11
o a SunFi e C18 OBD P ep column (250 mm
×
19 mm, 5
µ
m, Wa e s, Mil o d, MA, USA)
using 80% me hanol as an eluen (5.0 mL/min).
2.11. Ini ial Analysis o he Main Fla onoids in PFF
The ini ial analysis o he main la onoids in PFF was conduc ed as p e iously de-
sc ibed by Cho e al. [
29
] and Chao e al. [
30
]. B ie ly, each pu i ied sample was dissol ed
in me hanol (1 mg/mL), hen sample ilms we e do ed on po assium b omide c ys al
able s by he capilla y. The comp essed able s we e scanned by Fou ie ans o m in a ed
spec ome y (B uke , Rheins e en, Ge many) in a equency ange o 4000–400 cm
−1
, and
he in a ed abso p ion spec a o each pu i ied sample we e eco ded. Simul aneously,
hey we e also dilu ed and scanned om 200 o 600 nm using UV-Vis spec opho ome y
(The mo Fishe Scien i ic, Wal ham, MA, USA). Fu he mo e, liquid ch oma og aphy–mass
spec ome y (LC-MS) analysis was pe o med using LTQ O bi ap mass spec ome y
(The mo Fishe Scien i ic, Wal ham, MA, USA).
2.12. S a is ical Analysis
One-way ANOVA was ca ied ou o assess s a is ical signi icance using SPSS 20.0
(IBM, A monk, NY, USA). All g aphical e alua ions we e conduc ed by G aphPad P ism
8.0 (G aphPad, San Diego, CA, USA).
3. Resul s and Discussion
3.1. E ec s o PFF on he Le el o NO and Cy okines P oduced in RAW264.7 Cells
Mac ophages a e he mos impo an immune cells in a ious immune esponses,
especially in he immune esponse; hey can ini ia e and egula e in lamma o y p ocesses by
sec e ing he in lamma o y media o such as NO, as well as he p o-in lamma o y cy okines
such as TNF-
α
and IL-6 [
2
,
11
], so he e ec s o PFF on le els o NO and cy okines p oduced
in RAW264.7 cell we e in es iga ed. Fi s ly, he cell iabili y unde he PFF in e en ion
was de e mined. As illus a ed in Figu e 1, PFF exhibi ed no cy o oxic e ec on RAW264.7
cells wi h a concen a ion lowe han 200
µ
g/mL, so h ee concen a ions o PFF (50, 100,
and 200
µ
g/mL) we e selec ed o he ollowing expe imen . Then, NO, as a momen ous
ee adical in ol ed in he in lamma ion p ocess [
23
], was de e mined. I was obse ed
ha PFF signi ican ly inhibi ed NO p oduc ion in LPS-induced RAW264.7 cells and lowe ed
i s le el om 42.60
µ
M down o 7.70–23.51
µ
M a a concen a ion ange o 50–200
µ
g/mL
(p< 0.01) (Figu e 2A). Meanwhile, as shown in Figu e 2B, C, PFF ea men (50–200
µ
g/mL)
e icien ly supp essed he p oduc ion o TNF-
α
and IL-6 in a dose-dependen manne
(p< 0.01), and he inhibi o y a es we e 21.86–79.51% o TNF-
α
and 26.76–82.06% o
IL-6. The e o e, om he abo e expe imen al esul s, i could be ound ha PFF exhibi ed
an i-in lamma ion po en ial by supp essing some in lamma o y ac o s.
Foods 2023, 12, x FOR PEER REVIEW 6 o 12
Figu e 1. Effec s o PFF on cell iabili y o RAW264.7 cells. Da a we e exhibi ed as mean ± SD. ** p <
0.01, s. he con ol g oup.
Figu e 2. Effec s o PFF on p oduc ion o NO (A), IL-6 (B), and TNF-α (C) in LPS-induced RAW264.7
cells. Da a we e exhibi ed as mean ± SD. ** p < 0.01, s. he LPS- ea ed g oup (wi hou PFF).
3.2. Effec s o PFF on MAPK, PIK/Ak , and NF-κB Signaling Pa hways in RAW264.7 Cells
I has been epo ed ha MAPK and PI3K/Ak pa hways a e closely associa ed wi h
in lamma o y eac ions [31]. In pa icula , he phospho yla ion o some ex acellula sig-
nal kinases such as ERK, p38, JNK, and Ak ela ed o hese wo pa hways a e he im-
po an indexes o in lamma ion [2]. By Wes e n blo esul s, i could be ound ha he
phospho yla ion le els o ERK, p38, JNK, and Ak we e signi ican ly up- egula ed in LPS-
induced RAW264.7 cells (p < 0.01), which was consis en wi h he in lamma o y indica-
ions. Howe e , a e in e en ion wi h PFF (50–200 µg/mL), he phospho yla ion le els
o p38, JNK, and Ak we e signi ican ly educed in a dose-dependen manne (p < 0.01),
and educ ion a es we e 21.35–61.47% o p38, 15.88–29.10% o JNK, and 5.18–50.24% o
Ak (Figu e 3B–D). Meanwhile, he phospho yla ion le el o ERK was no e iden ly
changed a e ea men wi h PFF in a concen a ion anging om 50 o 100 µg/mL, bu i
was dec eased signi ican ly by 10.96% a doses o 200 µg/mL PFF (p < 0.01) (Figu e 3A).
Mo eo e , conside ing ha NF-κB, a i al ansc ip ion ac o mainly composed o IκB
and p65, plays a signi ican ole in egula ing mul iple in lamma o y diseases [32], he
impac s o PFF on NF-κB/p65 ansloca ion we e also s udied. The esul s (Figu e 4)
showed ha p65 p o ein was o e exp essed in he nuclea in LPS-induced RAW264.7
cells; howe e , i s exp ession was signi ican ly e e sed by PFF ea men (100 and 200
µg/mL), indica ing ha PFF dis u bed he ansloca ion o p65 s imula ed by LPS. Collec-
i ely, he abo e esul s sugges ed ha he an i-in lamma o y ac i i y o PFF was co e-
la ed wi h he ac i a ion o MAPK, PIK/Ak , and NF-κB signaling pa hways.
Figu e 1.
E ec s o PFF on cell iabili y o RAW264.7 cells. Da a we e exhibi ed as mean
±
SD.
** p< 0.01, s. he con ol g oup.

Foods 2023,12, 2889 6 o 11
Foods 2023, 12, x FOR PEER REVIEW 6 o 12
Figu e 1. Effec s o PFF on cell iabili y o RAW264.7 cells. Da a we e exhibi ed as mean ± SD. ** p <
0.01, s. he con ol g oup.
Figu e 2. Effec s o PFF on p oduc ion o NO (A), IL-6 (B), and TNF-α (C) in LPS-induced RAW264.7
cells. Da a we e exhibi ed as mean ± SD. ** p < 0.01, s. he LPS- ea ed g oup (wi hou PFF).
3.2. Effec s o PFF on MAPK, PIK/Ak , and NF-κB Signaling Pa hways in RAW264.7 Cells
I has been epo ed ha MAPK and PI3K/Ak pa hways a e closely associa ed wi h
in lamma o y eac ions [31]. In pa icula , he phospho yla ion o some ex acellula sig-
nal kinases such as ERK, p38, JNK, and Ak ela ed o hese wo pa hways a e he im-
po an indexes o in lamma ion [2]. By Wes e n blo esul s, i could be ound ha he
phospho yla ion le els o ERK, p38, JNK, and Ak we e signi ican ly up- egula ed in LPS-
induced RAW264.7 cells (p < 0.01), which was consis en wi h he in lamma o y indica-
ions. Howe e , a e in e en ion wi h PFF (50–200 µg/mL), he phospho yla ion le els
o p38, JNK, and Ak we e signi ican ly educed in a dose-dependen manne (p < 0.01),
and educ ion a es we e 21.35–61.47% o p38, 15.88–29.10% o JNK, and 5.18–50.24% o
Ak (Figu e 3B–D). Meanwhile, he phospho yla ion le el o ERK was no e iden ly
changed a e ea men wi h PFF in a concen a ion anging om 50 o 100 µg/mL, bu i
was dec eased signi ican ly by 10.96% a doses o 200 µg/mL PFF (p < 0.01) (Figu e 3A).
Mo eo e , conside ing ha NF-κB, a i al ansc ip ion ac o mainly composed o IκB
and p65, plays a signi ican ole in egula ing mul iple in lamma o y diseases [32], he
impac s o PFF on NF-κB/p65 ansloca ion we e also s udied. The esul s (Figu e 4)
showed ha p65 p o ein was o e exp essed in he nuclea in LPS-induced RAW264.7
cells; howe e , i s exp ession was signi ican ly e e sed by PFF ea men (100 and 200
µg/mL), indica ing ha PFF dis u bed he ansloca ion o p65 s imula ed by LPS. Collec-
i ely, he abo e esul s sugges ed ha he an i-in lamma o y ac i i y o PFF was co e-
la ed wi h he ac i a ion o MAPK, PIK/Ak , and NF-κB signaling pa hways.
Figu e 2.
E ec s o PFF on p oduc ion o NO (
A
), IL-6 (
B
), and TNF-
α
(
C
) in LPS-induced RAW264.7
cells. Da a we e exhibi ed as mean ±SD. ** p< 0.01, s. he LPS- ea ed g oup (wi hou PFF).
3.2. E ec s o PFF on MAPK, PIK/Ak , and NF-κB Signaling Pa hways in RAW264.7 Cells
I has been epo ed ha MAPK and PI3K/Ak pa hways a e closely associa ed wi h
in lamma o y eac ions [
31
]. In pa icula , he phospho yla ion o some ex acellula
signal kinases such as ERK, p38, JNK, and Ak ela ed o hese wo pa hways a e he
impo an indexes o in lamma ion [
2
]. By Wes e n blo esul s, i could be ound ha he
phospho yla ion le els o ERK, p38, JNK, and Ak we e signi ican ly up- egula ed in LPS-
induced RAW264.7 cells (p< 0.01), which was consis en wi h he in lamma o y indica ions.
Howe e , a e in e en ion wi h PFF (50–200
µ
g/mL), he phospho yla ion le els o
p38, JNK, and Ak we e signi ican ly educed in a dose-dependen manne (
p< 0.01
),
and educ ion a es we e 21.35–61.47% o p38, 15.88–29.10% o JNK, and 5.18–50.24%
o Ak (Figu e 3B–D). Meanwhile, he phospho yla ion le el o ERK was no e iden ly
changed a e ea men wi h PFF in a concen a ion anging om 50 o 100
µ
g/mL, bu i
was dec eased signi ican ly by 10.96% a doses o 200
µ
g/mL PFF (p< 0.01) (Figu e 3A).
Mo eo e , conside ing ha NF-
κ
B, a i al ansc ip ion ac o mainly composed o I
κ
B
and p65, plays a signi ican ole in egula ing mul iple in lamma o y diseases [
32
], he
impac s o PFF on NF-
κ
B/p65 ansloca ion we e also s udied. The esul s (Figu e 4)
showed ha p65 p o ein was o e exp essed in he nuclea in LPS-induced RAW264.7 cells;
howe e , i s exp ession was signi ican ly e e sed by PFF ea men (100 and 200
µ
g/mL),
indica ing ha PFF dis u bed he ansloca ion o p65 s imula ed by LPS. Collec i ely, he
abo e esul s sugges ed ha he an i-in lamma o y ac i i y o PFF was co ela ed wi h he
ac i a ion o MAPK, PIK/Ak , and NF-κB signaling pa hways.
Foods 2023, 12, x FOR PEER REVIEW 7 o 12
Figu e 3. Effec s o PFF on he exp ession o majo immune p o eins in MAPK and PI3K/Ak signal-
ing pa hways by wes e n blo ing. Rep esen a i e immunoblo s o p-ERK (A), p-JNK (B), p-p38 (C),
and p-Ak (D) p o eins a e shown. Da a we e exhibi ed as mean ± SD. * p < 0.05, ** p < 0.01, s. he
LPS- ea ed g oup (wi hou PFF).
Figu e 4. Effec s o PFF on p65 nuclea ansloca ion o LPS-s imula ed RAW264.7 cells.
Figu e 3.
E ec s o PFF on he exp ession o majo immune p o eins in MAPK and PI3K/Ak
signaling pa hways by wes e n blo ing. Rep esen a i e immunoblo s o p-ERK (
A
), p-JNK (
B
), p-p38
(
C
), and p-Ak (
D
) p o eins a e shown. Da a we e exhibi ed as mean
±
SD. * p< 0.05, ** p< 0.01,
s. he LPS- ea ed g oup (wi hou PFF).
Foods 2023,12, 2889 7 o 11
Foods 2023, 12, x FOR PEER REVIEW 7 o 12
Figu e 3. Effec s o PFF on he exp ession o majo immune p o eins in MAPK and PI3K/Ak signal-
ing pa hways by wes e n blo ing. Rep esen a i e immunoblo s o p-ERK (A), p-JNK (B), p-p38 (C),
and p-Ak (D) p o eins a e shown. Da a we e exhibi ed as mean ± SD. * p < 0.05, ** p < 0.01, s. he
LPS- ea ed g oup (wi hou PFF).
Figu e 4. Effec s o PFF on p65 nuclea ansloca ion o LPS-s imula ed RAW264.7 cells.
Figu e 4. E ec s o PFF on p65 nuclea ansloca ion o LPS-s imula ed RAW264.7 cells.
3.3. In es inal Regula o y Ac i i y o PFF
3.3.1. E ec s o PFF on he Gu Mic obio a
The inc easing e idence showed ha gu mic obio a and hei me aboli es a e closely
co ela ed wi h in lamma o y eac ions in o ganisms [
5
,
21
]. In his wo k, an
in i o
sim-
ula ion e men a ion by human ecal bac e ia was used o assess he p obio ic e ec s o
PFF acco ding o he BFBL gu model and explo e he co ela ion be ween gu mic obio a
and in es inal in lamma ion. Thus, we de e mined he a ge ed bac e ial coun in h ee
colon eac o s (R
1
, R
2
, and R
3
) used o simula e he human colon (Table 1). Compa ed
wi h he s abiliza ion pe iod (CK), 7-day PFF consump ion could inhibi se e al po en ially
pa hogenic bac e ia, including Alis ipes,Bilophia,En e obac e iaceae, and so on, which a e
gene ally co ela ed wi h in es inal mucosal inju y and in lamma o y diseases [
33
–
35
].
Howe e , he abundance o En e ococcus,Lac obacillus, and Rosebu ia was ob iously p o-
mo ed (p< 0.01). In addi ion, Bi idobac e ium also ended o inc ease sligh ly. Fo una ely,
all hese bac e ia can s eng hen he in es inal mucosal ba ie and ha e a posi i e ole in
alle ia ing in lamma ion by p oducing SCFAs [35–38].
3.3.2. E ec s o PFF on he Me aboli es
Conside ing some SCFA-p oducing bac e ia we e signi ican ly p omo ed by PFF, we
u he assessed he SCFA p oduc ion du ing he PFF in ake pe iod (Figu e 5). The esul
showed ha , du ing he s abiliza ion pe iod (CK), ace ic acid anked i s in SCFA con en ,
ollowed by p opionic acid and bu y ic acid. A e wa d, 7-day PFF consump ion ma kedly
inc eased he SCFA con en in R
1
, R
2
, and R
3
compa ed wi h he s abiliza ion pe iod
(CK) (
p< 0.05
). Among hese, he con en o ace ic acid, as he main componen o SCFAs,
inc eased by 1.19-, 1.03-, and 1.17- old in R
1
, R
2
, and R
3
, espec i ely. These esul s indica ed
ha PFF consump ion was a good sou ce o p omo e o SCFA in gu mic obio a. In
addi ion, high le els o SCFAs a e desi able because hei co esponding pH educ ion can
inhibi he g ow h o ha m ul bac e ia, he eby p e en ing colonic in lamma ion [
39
,
40
]. On
he whole, ou da a sugges ed a po en ial ole o PFF in a enua ing in es inal in lamma ion,
such as inc easing he ichness o speci ic bene icial bac e ia and con en o SCFAs, as well
as inhibi ing he g ow h o ha m ul bac e ia.
Foods 2023,12, 2889 8 o 11
Table 1.
qPCR alues (mean log copy numbe /mL
±
SD) o a ge ed mic obial g oup analysis in
ascending colon (R
1
), ans e se colon (R
2
), and descending colon (R
3
) o h ee expe imen pe iods
(CK, PFF, and WO). (* p< 0.05, ** p< 0.01, s. he CK).
Bac e ial G oup Compa men CK PFF WO
Alis ipes R17.07 ±0.01 5.31 ±0.21 ** 5.38 ±0.06 **
R28.69 ±0.07 8.58 ±0.14 8.36 ±0.06 *
R38.75 ±0.03 8.45 ±0.09 * 8.46 ±0.14 *
Bi idobac e ium R18.84 ±0.31 8.65 ±0.12 8.36 ±0.09
R28.30 ±0.38 8.65 ±0.20 8.46 ±0.08
R38.30 ±0.38 8.65 ±0.20 8.12 ±0.18
Bilophia R18.37 ±0.01 8.27 ±0.10 8.22 ±0.27
R28.39 ±0.01 8.16 ±0.09 8.23 ±0.24
R38.38 ±0.20 7.99 ±0.20 8.30 ±0.18
En e bac e iaceae R18.60 ±0.00 8.26 ±0.02 ** 7.83 ±0.05 **
R28.49 ±0.01 8.12 ±0.05 ** 7.90 ±0.02 **
R38.48 ±0.05 7.91 ±0.13 ** 8.03 ±0.04 **
En e ococcus R16.48 ±0.08 8.56 ±0.21 ** 8.87 ±0.12 **
R26.42 ±0.13 8.84 ±0.13 ** 8.82 ±0.01 **
R37.09 ±0.04 8.44 ±0.21 ** 8.40 ±0.02 **
Lac obacillus R13.68 ±0.00 3.99 ±0.02 ** 5.54 ±0.04 **
R23.60 ±0.03 4.44 ±0.15 ** 5.41 ±0.00 **
R33.98 ±0.00 4.42 ±0.07 ** 5.28 ±0.05 **
Rosebu ia R15.64 ±0.09 6.47 ±0.19 ** 4.93 ±0.02 **
R26.23 ±0.07 6.58 ±0.06 ** 5.56 ±0.03 **
R36.01 ±0.03 6.47 ±0.10 ** 5.29 ±0.06 **
Foods 2023, 12, x FOR PEER REVIEW 9 o 12
can inhibi he g ow h o ha m ul bac e ia, he eby p e en ing colonic in lamma ion
[39,40]. On he whole, ou da a sugges ed a po en ial ole o PFF in a enua ing in es inal
in lamma ion, such as inc easing he ichness o speci ic bene icial bac e ia and con en o
SCFAs, as well as inhibi ing he g ow h o ha m ul bac e ia.
Figu e 5. Effec s o PFF on SCFAs con en in he BFBL gu model. SCFAs con en in he ascending
colon (R1), ans e se colon (R2), and descending colon (R3) o h ee expe imen pe iods (CK, PFF,
and WO). Da a we e exhibi ed as mean ± SD. * p < 0.05, ** p < 0.01, s. he CK.
3.4. Ini ial Analysis o he Main Fla onoids in PFF
To con i m he componen basis o PFF on he effec o in lamma ion o gu mic obi-
o a, he bioac i e componen s o PFF we e u he analyzed using spec oscopic me hods.
The esul showed ha PFF con ained i e main compounds isola ed and iden i ied as
la onoids by HPLC combined wi h UV-Vis and FT-IR spec a (Figu es S2–S4). Mo eo e ,
LC-MS da a also showed ha he excime ion peaks [M-H]- o he i e la onoid com-
pounds we e 609.14691, 593.15125, 563.14044, 609.14630, and 593.15112, espec i ely (Fig-
u e S5). Based on he abo e da a and ele an e e ences [27,32,41–45], he i e compounds
we e p elimina ily in e ed as o ien in-2″-O-galac oside, apigenin-6,8-di-C-glucoside, i-
exin-2″-O-xyloside, o ien in-2″-O-glucoside, and i exin-2″-O-glucoside, espec i ely.
Fla onoids and hei de i a i es can p e en and ea a ious diseases, including in lam-
ma o y diseases [46]. P e ious s udies epo ed ha o ien in could effec i ely alle ia e
in lamma o y eac ions in LPS-induced RAW 264.7 cells [47,48], i exin could down- eg-
ula e in lamma o y media o s and educe he mig a ion o neu ophils o he in lamma-
o y ocus [49], and apigenin could ligh en he LPS-s imula ed BV2 mic oglia by inhibi ing
he elease o p o-in lamma o y cy okines [50]. Hence, hese i e la onoid compounds
may play a key ole in he an i-in lamma o y ac i i y exe ed by PFF, bu hei s uc u es
and biological ac i i ies s ill equi e u he analysis and de e mina ion. O e all, his
s udy could p omo e he de elopmen o no el na u al an i-in lamma o y agen s based
on bioac i e la onoids.
4. Conclusions
In his s udy, PFF ex ac ed om P. oe ida ui s could effec i ely inhibi he biosyn-
hesis and p oduc ion o he in lamma o y media o (NO) and p o-in lamma o y cy o-
kines (TNF-α and IL-6) om elie ing he symp oms o in lamma o y esponses. Mo eo-
e , i could also ob iously down- egula e he phospho yla ion le els o p o-in lamma-
o y p o eins (ERK, JNK, p38, Ak , and p65) in ol ed in egula ing MAPK, PI3K/Ak , and
NF-κB signaling pa hways. Mo e impo an ly, PFF exhibi ed he g ow h-p omo ing abil-
i y o se e al bene icial bac e ia, including Bi idobac e ium, En e ococcus, Lac obacillus, and
Rosebu ia, and SCFA gene a ion abili y in gu mic obio a. These me abolism effec s could
be conside ed o alle ia e in lamma o y eac ions. In addi ion, PFF mainly consis s o i e
la onoid compounds, which migh be ac i e compounds wi h an i-in lamma o y
Figu e 5.
E ec s o PFF on SCFAs con en in he BFBL gu model. SCFAs con en in he ascending
colon (R
1
), ans e se colon (R
2
), and descending colon (R
3
) o h ee expe imen pe iods (CK, PFF,
and WO). Da a we e exhibi ed as mean ±SD. * p< 0.05, ** p< 0.01, s. he CK.
3.4. Ini ial Analysis o he Main Fla onoids in PFF
To con i m he componen basis o PFF on he e ec o in lamma ion o gu mi-
c obio a, he bioac i e componen s o PFF we e u he analyzed using spec oscopic
me hods. The esul showed ha PFF con ained i e main compounds isola ed and iden-
i ied as la onoids by HPLC combined wi h UV-Vis and FT-IR spec a (Figu es S2–S4).
Mo eo e , LC-MS da a also showed ha he excime ion peaks [M
−
H]
−
o he i e
la onoid compounds we e 609.14691, 593.15125, 563.14044, 609.14630, and 593.15112,
espec i ely (Figu e S5). Based on he abo e da a and ele an e e ences [
27
,
32
,
41
–
45
], he
i e compounds we e p elimina ily in e ed as o ien in-2
00
-O-galac oside, apigenin-6,8-di-
C-glucoside, i exin-2
00
-O-xyloside, o ien in-2
00
-O-glucoside, and i exin-2
00
-O-glucoside,
espec i ely. Fla onoids and hei de i a i es can p e en and ea a ious diseases,
including in lamma o y diseases [
46
]. P e ious s udies epo ed ha o ien in could e -
ec i ely alle ia e in lamma o y eac ions in LPS-induced RAW 264.7 cells [
47
,
48
], i exin
could down- egula e in lamma o y media o s and educe he mig a ion o neu ophils o
Foods 2023,12, 2889 9 o 11
he in lamma o y ocus [
49
], and apigenin could ligh en he LPS-s imula ed BV2 mic oglia
by inhibi ing he elease o p o-in lamma o y cy okines [
50
]. Hence, hese i e la onoid
compounds may play a key ole in he an i-in lamma o y ac i i y exe ed by PFF, bu hei
s uc u es and biological ac i i ies s ill equi e u he analysis and de e mina ion. O e all,
his s udy could p omo e he de elopmen o no el na u al an i-in lamma o y agen s based
on bioac i e la onoids.
4. Conclusions
In his s udy, PFF ex ac ed om P. oe ida ui s could e ec i ely inhibi he biosyn he-
sis and p oduc ion o he in lamma o y media o (NO) and p o-in lamma o y cy okines
(TNF-
α
and IL-6) om elie ing he symp oms o in lamma o y esponses. Mo eo e ,
i could also ob iously down- egula e he phospho yla ion le els o p o-in lamma o y
p o eins (ERK, JNK, p38, Ak , and p65) in ol ed in egula ing MAPK, PI3K/Ak , and
NF-
κ
B signaling pa hways. Mo e impo an ly, PFF exhibi ed he g ow h-p omo ing abil-
i y o se e al bene icial bac e ia, including Bi idobac e ium,En e ococcus,Lac obacillus, and
Rosebu ia, and SCFA gene a ion abili y in gu mic obio a. These me abolism e ec s could
be conside ed o alle ia e in lamma o y eac ions. In addi ion, PFF mainly consis s o
i e la onoid compounds, which migh be ac i e compounds wi h an i-in lamma o y
p ope ies. The e o e, la onoids de i ed om P. oe ida ui , as new p e en i e and he a-
peu ic subs ances, p o ide he possibili y o de elop unc ional componen s o alle ia e
in lamma o y diseases in he ood and pha maceu ical indus ies.
Supplemen a y Ma e ials:
The ollowing suppo ing in o ma ion can be downloaded a : h ps://
www.mdpi.com/a icle/10.3390/ oods12152889/s1, Table S1: P ime s and ampli ica ion condi ions
o eal- ime PCR assays. Figu e S1: Schema ic diag am o BFBL gu model; Figu e S2: HPLC
ch oma og aphy spec um o PFF; Figu e S3: The UV-Vis spec a o pu i ied compounds
1
–
5
; Figu e
S4: The FT-IR spec a o pu i ied compounds
1
–
5
; Figu e S5: The LC-ESI-MS spec a o pu i ied
compound 1(A), 2(B), 3(C), 4(D), and 5(E).
Au ho Con ibu ions:
Concep ualiza ion, H.W. and T.R.; me hodology, Y.S.; so wa e, X.H.; ali-
da ion, M.Z.; o mal analysis, X.H.; in es iga ion, Y.S.; da a cu a ion, Y.S.; w i ing—o iginal d a
p epa a ion, X.H. and Y.S.; w i ing— e iew and edi ing, R.H., M.L. and H.W.; supe ision, H.W. All
au ho s ha e ead and ag eed o he published e sion o he manusc ip .
Funding:
This esea ch was unded by he Na u al Science Founda ion o China (31972157), Ling-
nan Mode n Ag icul u al Science and Technology Guangdong Labo a o y Independen Scien-
i ic Resea ch P ojec (NZ2021032), Guangdong P o incial Key Labo a o y o Food Quali y and
Sa e y (2020B1212060059), Spanish Minis y o Science and Inno a ion (AGL2016-75951-R, PID2019-
106071RB-I00), Sou h China Ag icul u al Uni e si y Doc o al S uden s (o e seas) Join Educa ion
P og ams (2018LHPY003), Na u al Science Founda ion o Guizhou P o ince (ZK[2023]451).
Da a A ailabili y S a emen : All da a a e epo ed in he a icle.
Acknowledgmen s: The au ho s acknowledge echnical suppo o Es eban Sáez and Da id Galán.
Con lic s o In e es : The au ho s decla e no con lic o in e es .
Re e ences
1.
Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. In lamma o y esponses and in lamma ion-
associa ed diseases in o gans. Onco a ge 2018,9, 7204–7218. [C ossRe ]
2.
Jung, J.; Kim, H.; Lee, S.; Hong, M.; Hwang, D. An ioxidan and an i-in lamma o y ac i i y o Filipendula glabe ima Nakai
e hanolic ex ac and i s chemical composi ion. Molecules 2022,27, 4628. [C ossRe ] [PubMed]
3.
Ghasemian, M.; Owlia, S.; Owlia, M.B.; Chi, H.C.; Cho, C.H. Re iew o an i-in lamma o y he bal medicines. Ad . Pha macol. Sci.
2016,2016, 9130979. [C ossRe ]
4.
Cao, Y.; Gao, J.; Zhang, L.; Qin, N.; Zhu, B.; Xia, X. Jelly ish skin polysaccha ides enhance in es inal ba ie unc ion and modula e
he gu mic obio a in mice wi h DSS-induced coli is. Food Func . 2021,12, 10121–10135. [C ossRe ]
5.
He, X.; Liu, D.; Liu, H.; Wu, D.; Li, H.; Zhang, X.; Gan, R. P e en ion o ulce a i e coli is in mice by swee ea (Li hoca pus
li sei olius) ia he egula ion o gu mic obio a and bu y ic-acid-media ed an i-in lamma o y signaling. Nu ien s
2022
,14, 2208.
[C ossRe ] [PubMed]